Vimarsana
Biggest News Aggregation in the World

Page 49 - E Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from E Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In E Ltd Today - Breaking & Trending Today

Covid-19: Countries send aid to ease India's oxygen emergency - Vimarsana News

Covid-19: Countries send aid to ease India's oxygen emergency

International efforts are underway to help India as the country suffers critical oxygen shortages amid a devastating surge in Covid-19 cases.

Source: rnz.co.nz
US President Biden needs to help India now - The Hindu BusinessLine - Vimarsana News

US President Biden needs to help India now - The Hindu BusinessLine

Covid-19: US President Biden needs to help India now Joe Biden, President, USA   -  AP× RELATED US should share doses from its own supply of Oxford-AstraZeneca, J&J vaccines India has become the terrifying new epicentre of the Covid-19 pandemic. New cases have topped 300,000 daily and are still rising; the official death toll of over 2,000 per day is almost certainly an underestimate. Every hour brings horrifying new stories of mass cremations, overwhelmed testing centres, people dying while waiting for a hospital bed. The country desperately needs help — and the United States (US) shou...

Biological E gets CDSCO's nod for phase III trials of its Covid-19 vaccine candidate - Vimarsana News

Biological E gets CDSCO's nod for phase III trials of its Covid-19 vaccine candidate

April 24, 2021 The Phase III clinical study to be conducted in 15 sites across India Biological E. Ltd, has successfully completed the Phase I and II clinical trial of its Covid-19 subunit vaccine candidate in India and received the approval to start the Phase III clinical trial from the Central Drugs Standard Control Organization (CDSCO) - Subject Expert Committee (SEC). Its candidate includes an antigen developed by Texas Children’s Hospital Center for Vaccine Development and in-licensed from BCM Ventures, Baylor College of Medicine’s integrated commercialization team, along with Dyna...

Bio E's Covid-19 vaccine candidate gets SEC nod for phase-III trials - Vimarsana News

Bio E's Covid-19 vaccine candidate gets SEC nod for phase-III trials

Bio E's Covid-19 vaccine candidate gets SEC nod for phase-III trials Top Searches Bio E's Covid-19 vaccine candidate gets SEC nod for phase-III trials Swati Bharadwaj / TNN / Apr 24, 2021, 15:39 IST FacebookTwitterLinkedinEMail Two shots of the intramuscular vaccine were administered 28 days apart as part of the study that evaluated the safety and immunogenicity of the vaccine candidate. (Representative image) HYDERABAD: Vaccine maker Biological E Ltd on Saturday said it has received approval of the subject expert committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) to ...

Coronavirus updates | J&J vaccine expected to be imported to India by July, says media report - Vimarsana News

Coronavirus updates | J&J vaccine expected to be imported to India by July, says media report

Coronavirus updates | J&J vaccine expected to be imported to India by July, says media report Updated: Updated: April 23, 2021 12:35 IST The UAE, the U.K., the U.S., Canada, Hong Kong and New Zealand restrict travellers from India. Share Article AAA A worker carries fans in a stadium, which has been converted into quarantine centre for coronavirus patients, in Kolkata.   | Photo Credit: AFP The UAE, the U.K., the U.S., Canada, Hong Kong and New Zealand restrict travellers from India. Following the surge in COVID-19 cases, the UAE has become the latest of many countries to restrict traveller...